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Abstract
Background: Klotho is a renal protein with anti-aging properties that is downregulated in conditions related to kidney
injury. Hyperlipidemia accelerates the progression of renal damage, but the mechanisms of the deleterious effects of
hyperlipidemia remain unclear.
Methods: We evaluated whether hyperlipidemia modulates Klotho expression in kidneys from C57BL/6 and hyperlipidemic
apolipoprotein E knockout (ApoE KO) mice fed with a normal chow diet (ND) or a Western-type high cholesterol-fat diet
(HC) for 5 to 10 weeks, respectively.
Results: In ApoE KO mice, the HC diet increased serum and renal cholesterol levels, kidney injury severity, kidney
macrophage infiltration and inflammatory chemokine expression. A significant reduction in Klotho mRNA and protein
expression was observed in kidneys from hypercholesteromic ApoE KO mice fed a HC diet as compared with controls, both
at 5 and 10 weeks. In order to study the mechanism involved in Klotho down-regulation, murine tubular epithelial cells were
treated with ox-LDL. Oxidized-LDL were effectively uptaken by tubular cells and decreased both Klotho mRNA and protein
expression in a time- and dose-dependent manner in these cells. Finally, NF-kB and ERK inhibitors prevented ox-LDL-
induced Klotho downregulation.
Conclusion: Our results suggest that hyperlipidemia-associated kidney injury decreases renal expression of Klotho.
Therefore, Klotho could be a key element explaining the relationship between hyperlipidemia and aging with renal disease.
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Introduction
Chronic kidney disease (CKD) has features consistent with
accelerated aging, such as augmented atherosclerosis [1]. Abnor-
malities in lipid and lipoprotein metabolism frequently accompany
renal disease and are thought to be involved in the pathogenesis of
renal injury [2,3]. Hyperlipidemia is associated with formation of
oxidized low-density lipoprotein (ox-LDL). Accumulation of ox-
LDL has been reported in the circulation and renal interstitium of
patients with CKD and end stage-renal disease [4]. In the kidney,
these atherogenic lipoproteins are cytotoxic, promote macrophage
recruitment, enhance oxidative stress, and promote pro-inflam-
matory cytokines expression [5,6], changes that may compromise
renal function [7–9].
Klotho is a kidney protein that plays a pivotal role in regulating
aging and the development of age-related diseases [10,11]. Klotho
knockout mice exhibit multiple aging-like phenotypes, including
atherosclerosis, osteoporosis, emphysema and infertility [10]. By
contrast, in vivo Klotho gene delivery can ameliorate vascular
endothelial dysfunction, increase nitric oxide production, reduce
elevated blood pressure, and prevent fibrosis [12]. Klotho
antiaging properties include modulation of Ca2+/Pi homeostasis
[13,14], antioxidant effects [15], suppression of insulin-like growth
factor I signaling [11], protection of endothelium through
induction of endothelial nitric oxide synthesis, inhibition of tumor
necrosis factor (TNF)-a-induced nuclear factor (NF)-kB activity
and expression of endothelial adhesion molecules [16,17]. Kidney
Klotho is downregulated in sustained hypertension, diabetes
mellitus, and CKD models [18] as well as in experimental
ischemia-reperfusion-induced or nephrotoxic acute kidney injury
(AKI) [19,20]. Furthermore, decreased expression of Klotho
mRNA and protein was confirmed in human CKD [21].
To date, the regulatory mechanisms of Klotho gene expression
remains poorly understood. Klotho expression is reduced by acute
inflammatory stress in vivo [22], and also by angiotensin II and
oxidative stress in tubular cells both in cell culture and in vivo [23–
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26]. Statins and Rho kinase inhibitors prevented angiotensin-
induced downregulation of Klotho in cultured cells [24]. In
addition, pro-inflammatory cytokines TWEAK (Tumor necrosis
factor like weak inducer of apoptosis) and TNF-a may also reduce
renal Klotho expression throughout NF-kB activation [19].
Because renal failure and hyperlipidemia are both associated
with accelerated aging features, such as atherosclerosis, oxidative
stress and endothelial dysfunction, characteristics also observed in
Klotho knockout mice [10–12,25], in this study we investigated the
impact of hyperlipidemia-associated renal damage on Klotho
expression in kidneys from control and hyperlipidemic Apolipo-
protein E (ApoE)-knockout (ApoE KO) mice, a widely used model
to study the effect of early onset hyperlipidemia on renal injury
[27,28]. Furthermore, we analyzed the effect of ox-LDL on
Klotho expression in renal tubular epithelial cells as well as the
signaling pathways involved in the modulation of klotho expres-
sion by these modified lipoproteins.
Materials and Methods
Animal Model
One experimental design studied early renal lesions. Sixteen
male C57BL/6 mice (Harlan laboratories) and sixteen male ApoE
knockout mice (12 weeks of age; Jackson Laboratories) were
randomly divided in two groups fed either a normal (ND, 5.0%
fat, 0.05% cholesterol) or a high fat hyperlipidemic diet (HC,
21.2% fat, 0.15% cholesterol) +16.7% proteins) for 5 weeks. A
second experimental design studied advanced renal lesions.
Sixteen male C57BL/6 mice and sixteen male ApoE knockout
mice (16 weeks of age) were fed a ND or HC for 10 weeks. Blood
was collected in serum tubes and stored at 280uC until used.
Cholesterol was tested in serum samples (Thermo Trance).
Anesthetized mice were saline-perfused. One kidney was snap-
frozen in liquid nitrogen for RNA and protein studies, and the
other kidney was fixed in 4% paraformaldehyde, embedded in
paraffin and used for immunohistochemistry.
Renal Histophatologic Studies and Immunochemistry
To assess histological changes, paraffin-embedded kidneys were
cross-sectioned into 5 mm thick pieces and Masson trichrome
stained. Samples were examined by an outside pathologist (JB)
blinded to the nature of the samples. Tissue sections were scored
according to the extent of glomerular changes (hypertrophy,
hypercellularity, mesangial proliferation, ischemia, sclerosis, foam
cells and fibrosis), tubular (loss of brush border, vacuolization,
desquamation, tubular dilation) and interstitial damage (interstitial
fibrosis and interstitial infiltrate) in a semiquantitative scale from 0
to 3, and results from each item were added to yield the tubular,
glomerular or interstitial injury score.
Immunohistochemistry was carried out as described previously
in paraffin embedded tissue sections 5 mm thick [19]. Primary
antibodies were rat polyclonal anti-F4/80 antigen (1:50, Serotec),
goat polyclonal anti-monocyte chemotactic protein-1 (MCP-1) (1/
100, Santa Cruz Biotechnology, Santa Cruz, California) and
rabbit polyclonal anti-Regulated on Activation, Normal T Cell
Expressed and Secreted (RANTES) (1/200, Antibodies-online,
Aachen, Germany). Sections were counterstained with Carazzi‘s
hematoxylin. Negative controls included incubation with a
nonspecific Ig of the same isotype as the primary antibody.
Results were expressed as percentage positive area versus total
area of RANTES and MCP-1 staining in 20 randomly selected
fields (x100) per sample. Quantification of F4/80 positive-stained
cells was made by determining the total number of positive cells/
total number of cells in 20 randomly chosen fields (x100) using
Image-Pro Plus software (Media Cybernetics, Silver Spring, MD).
Samples from each animal were examined in a blinded manner.
Lipids were detected by Oil red O staining as previously reported
[6].
For immunofluorescence studies, murine proximal tubular
epithelial cells (MCT) and murine distal tubular epithelial cells
(NP-1) were plated onto Labtek slides, fixed in 4% paraformal-
dehyde and permeabilized in 0.2% Triton X-100/PBS, washed in
PBS, and incubated with rabbit polyclonal anti-Klotho (1:100.
Calbiochem, La Jolla, California), followed by Alexa 488
secondary antibody (1:200, Invitrogen, Eugene, Oregon, USA)
or Alexa 633 secondary antibody (1:200, Invitrogen, Eugene,
Oregon, USA). Nuclei were counterstained with propidium iodide
or 49-6-diamidino-2-phenylindole (DAPI). Klotho-expressing tu-
bular cells in kidney from normal mice were detected using the
anti-Klotho antibody with secondary Alexa Fluor 633 and then
stained with the proximal tubule marker, fluorescein-conjugated
Tetranogolobus lotus (1:33, Sigma).
Time of Flight Secondary Ion Mass Spectrometry (TOF-
SIMS)
Samples were kept at -80uC until 10-mm slices were cut using a
cryostat (CM1900; Leica) at a constant temperature of 225uC.
Tissue sections were deposited onto a stainless steel plate (15-7PH;
Goodfellow) and stored again at 280uC. After drying under a
pressure of a few hPa for 15 min, they were directly analyzed in a
TOF-SIMS V mass spectrometer (IonTof, Germany) fitted with a
bismuth cluster ion source located at the Parque Cientifico de
Barcelona, Spain. The primary ions impinge the surface of the
tissue section with a kinetic energy of 25 keV. The primary ion
dose was between 4.761011 and 1012 ions/cm2. The secondary
ions were extracted with 2 keV energy and postaccelerated to
10 keV just before hitting the detector surface (single-channel plate
followed by a scintillator and a photomultiplier). A low-energy
electron flood gun was activated to neutralize the surface during
the analysis. The effective ion flight path is ,2 m using a
reflectron, and the mass resolution is ,6,300 (full width at half-
maximum) at a mass-to-charge ratio (m/z) of 35 and 10,000 at
795.7 m/z. Mass calibration and ion peak identifications were
performed as previously described [29]. Color scales correspond to
the interval (0, maximal number of counts in a pixel).
Isolation and Oxidation of LDL
Human LDL were isolated from a fresh plasma pool by
sequential ultracentrifugation (2 hour at 405,000 g and 4uC)
immediately after separation of plasma at density between 1.019
and 1.063 and after very low density lipoprotein (VLDL) isolation
Figure 1. Murine model of renal damage induced by hyperlipidemia. (A) Serum cholesterol levels from C57BL/6 (WT) and ApoE knockout
(ApoE) mice fed a normal chow diet (ND) or a hyperlipidemic diet (HC) for 5 or 10 weeks. (B) Semiquantitative assessment and representative
secondary ion images under the irradiation of bismuth cluster showing lipid content in kidneys from mice at 10 weeks of dietary intervention. In
order to normalize tissue size variation, metabolite measurements were expressed as % relative intensity = ratio between the metabolite area and
total tissue area (phosphate area) (C) Representative Masson trichrome staining in mouse kidneys and semiquantitative assessment of lesions in
glomerular, tubular and interstitial compartments. Original magnification x 100. *p,0.05 vs WT with ND in each time-period, { p,0.05 vs WT with HC
in each time-period, ` p,0.05 vs ApoE knockout mice with ND in each time-period. Values shown are mean6SD, n=8 per group.
doi:10.1371/journal.pone.0083713.g001
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Figure 2. Inflammatory response and oxidative stress in murine kidneys. Representative inmunohistochemistry (A) and semiquantitative
assessment (B–C) of renal macrophage infiltration (F4/80) and inflammatory cytokines (RANTES and MCP-1) in kidneys from C57BL/6 (WT) and ApoE
knockout (ApoE) mice fed normal chow-(ND) or hyperlipidemic-diet (HC) for 5 or 10 weeks. Original magnification x 100. (D) Expression of MCP-1 and
RANTES, as determined by real time RT-PCR, in kidneys from all the studied groups. (E) Representative DHE staining and semiquantitative DHE
assessment in kidneys from all mice groups (magnification x 200). *p,0.05 vs WT with ND in each time-period, { p,0.05 vs WT with HC in each time-
period, ` p,0.05 vs ApoE knockout mice with ND in each time-period. Values shown are mean6SD, n=8 per group.
doi:10.1371/journal.pone.0083713.g002
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at d,1.019 using a Beckman model LE-70 ultracentrifuge with a
Type NVT65 rotor (Beckman). The LDL fraction was dialyzed for
24 hours at 4uC with 3 exchanges of PBS, containing 0.01%
EDTA for the first and only PBS for the 2 other exchanges. LDL
protein content was determined by using the method of Bradford.
LDL oxidation was carried out by incubating 200 mg/mL LDL
protein with 5 mmol/L CuSO4 in 1.0 mL PBS medium at 37uC
for 120 minutes. The reaction was stopped by adding 100 mmol/
L EDTA at 4uC and immediately dialyzed to eliminate EDTA.
Oxidized-LDL were filtered and stored at 4uC in nitrogen
atmosphere.
Cell Culture
MCT and NP-1 cells were cultured in RPMI 1640 or DMEM,
respectively, supplemented with decomplemented fetal bovine
serum (10%), glutamine (2 mmol/l), and penicillin/streptomycin
(100 U/ml; LONZA, Verviers, Belgium) in 5% CO2 at 37 uC.
Both cell lines were originated from the kidneys of SJL mice in the
University of Pennsylvania and obtained from Eric G Neilson and
Frank Strutz, respectively [30]. Cell viability experiments were
performed by propidium iodide flow cytometry as previously
reported [31]. For inhibition experiments, cells were pre-treated
for 1 hour with inhibitors of Phosphoinositide 3-Kinase (PI3K)
(LY294002, 20 mM, Sigma), NF-kB (Parthenolide, 1 mM, Sigma),
Jun N-terminal kinase (JNK) (SP600125, 10 mM, Stressgen
Bioreagents), p38 (SB203580, 10 mM, Stressgen Bioreagents),
extracellular signal-regulated kinase (ERK) (PD98059, 50 mM,
Stressgen Bioreagents), and then stimulated with ox-LDL (25 mg/
mL).
ELISA
Concentrations of murine MCP-1 (BD Pharmingen), inter-
leukine 6 (IL-6) (BD Pharmingen) and RANTES (Bender
MedSystems) in the supernatants of the cell cultures were
determined by ELISA, following the manufacturer’s instructions.
RNA Extraction and Real-time PCR
Total RNA from kidneys or cultured cells was obtained by
Trizol method (Invitrogen, Carlsbad, CA, USA) and reverse-
transcribed with High Capacity cDNA Archive Kit and real-time
PCR was performed on a ABI Prism 7500 PCR system (Applied
Biosystems, Foster City, California) using the DeltaDelta Ct
method. Expression levels are given as ratios to Glyceraldehyde 3-
phosphate dehydrogenase (GADPH). Predeveloped primer and
probe assays were obtained for murine GADPH, RANTES, TNF-
alpha, MCP-1, IL-6 and Klotho (Applied Biosystems).
Western Blot
Cell samples or tissues were homogenized in lysis buffer (50 mM
TrisHCl, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 0.2%
Triton X-100, 0.3% NP-40, 0.1 mM PMSF, and 1 mg/ml
pepstatin A) and then separated by 10% SDS-PAGE under
reducing conditions. After electrophoresis, samples were trans-
ferred to PVDF membranes (Millipore, Bedford, Massachusetts),
blocked with 5% skimmed milk in PBS/0.5% vol/vol Tween 20
for 1 h, washed with PBS/Tween, and incubated with rabbit
polyclonal anti-Klotho (1:500, Calbiochem, La Jolla, California),
IkB-alpha (sc-371, Santa Cruz), b-actin (sc-47778, Santa Cruz), p-
ERK (sc-7383, Santa Cruz), and ERK (sc-154, Santa Cruz).
Antibodies were diluted in 5% milk PBS/Tween. Blots were
washed with PBS/Tween and incubated with appropriate
horseradish peroxidase-conjugated secondary antibody (1:2000,
Amersham, Aylesbury, UK). After washing with PBS/Tween the
blots were developed with the chemiluminescence method (ECL,
Amersham). Blots were then probed with mouse monoclonal anti-
a-tubulin antibody (1:2000, Sigma), and levels of expression were
corrected for minor differences in loading. Quantification was
expressed as arbitrary densitometric units (AU).
Measurement of NADPH-dependent ROS Production and
Detection of Superoxide Anion
A lucigenin-enhanced chemiluminescence assay [32] was used
to determine the nicotinamide adenine dinucleotide phosphate-
oxidase (NADPH)-dependent reactive-oxygen species (ROS)
production activity in MCT cells lysates. The reaction mixture
comprised 50 mM phosphate buffer containing 1 mM EGTA
(pH 7.0), 5 mM lucigenin, and 0.1 mM NADPH. Chemilumines-
cence was measured for 5 min after the addition of NADPH and
recorded in a Sirius luminometer (Berthold Detection System).
ROS production was determined from the ratio of the relative
light units to the total protein levels and expressed as fold vs. basal.
Dihydroethidium (DHE; Molecular Probes, Invitrogen) was used
to evaluate in situ levels of superoxide as described previously [33].
Statistical Analysis
Statistical analysis was performed using SPSS 11.0 statistical
software. Significance at the p,0.05 level was assessed by
Student’s t-test for two groups of data and ANOVA for three or
more groups. In vitro experiments were replicated three times for
each incubation period. Pearson differences were considered
significant at a value of p,0.05.
Ethics Statement
The housing and care of animals and all the procedures carried
out in this study were strictly in accordance with the Directive
2010/63/EU of the European Parliament and were approved by
the Institutional Animal Care and Use Committees of IIS-
Fundacion Jimenez Diaz.
Results
Hyperlipidemia Increases Kidney Lipid Deposits and
Aggravates Renal Damage
As expected, serum cholesterol levels were much higher in
ApoE KO mice than in C57BL/6 wild type mice (WT)
(Figure 1A). HC diet induced an increase in total cholesterol in
both WT and ApoE KO mice, but hyperlipidemia was more
pronounced in ApoE KO mice. In order to determine whether
Figure 3. Decreased Klotho expression in kidneys from hyperlipidemic mice. (A) Localization of renal Klotho using anti-Klotho with
secondary Alexa Fluor 488–conjugated antibody (green) in a normolipidemic WT mice. (B) Klotho-expressing tubular cells in kidney from WT mice
were detected using anti-Klotho with secondary Alexa Fluor 633–conjugated antibody (red) and then stained with proximal tubule marker FITC-
Tetranogolobus lotus (green). Nuclei were stained with DAPI (blue). Arrows and arrowheads identify Klotho expression in proximal and distal nephron
tubules, respectively. (C) Total Klotho kidney protein expression, as determined by Western-blot in kidneys from C57BL/6 (WT) and ApoE knockout
(ApoE) mice fed normal chow-(ND) or hyperlipidemic-diet (HC) for 5 or 10 weeks. (D) Klotho mRNA expression in kidneys as determined by real time
RT-PCR. *p,0.05 vs WT with ND in each time-period, { p,0.05 vs WT with HC in each time-period, ` p,0.05 vs ApoE knockout mice with ND in
each time-period. Values shown are mean6SD, n=8 per group.
doi:10.1371/journal.pone.0083713.g003
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hyperlipidemic mice show enhanced renal lipid accumulation, we
performed metabolomic TOF-SIMS imaging analysis [29]. Renal
samples subjected to TOF-SIMS analysis had a strong bias toward
hydrophobic molecules, displaying high-resolution images of the
most abundant lipids and lipid derivatives present on the sample
surface. Kidneys from hyperlipidemic ApoE KO mice fed a HC
diet showed an increased accumulation of cholesterol and
triglycerides as compared with WT mice fed a ND (Figure 1B).
Furthermore, HC increased kidney palmitic acid (C16:0) and
linoleic acid (C18:2) in both WT and ApoE KO mice. Finally, we
also observed increased neutral lipid accumulation, as determined
by oil red O staining, mainly in glomeruli from ApoE KO mice fed
a HC for 10 weeks; whereas a mild staining or no glomerular
staining was observed in ApoE KO mice on ND or WT mice,
respectively (Fig. S1). All together, these data strongly indicated
that there were excessive amounts of lipid deposits in the kidneys
of ApoE KO mice fed a HC.
Standard histological analysis showed increased glomerular,
tubular and interstitial renal damage in hyperlipidemic ApoE KO
mice after HC as compared to WT fed either ND or HC diet
(Figure 1C). The main renal findings in ApoE KO mice fed HC
included accumulation of foam cells in glomeruli, increased
mesangial proliferation and interstitial inflammatory infiltrates.
We also observed tubular dilation, vacuolization and loss of brush
border in tubular epithelium of these hyperlipidemic mice.
Furthermore, ApoE KO mice fed HC presented significantly
more severe glomerular, tubular and interstitial renal damage, as
compared with ApoE KO mice fed a ND diet. All these differences
increased as duration of HC augmented.
Increased Renal Inflammation and Oxidative Stress in
Hyperlipidemic Mice
An increased tubulointerstitial inflammation, characterized by
increased number of interstitial F4/80-positive macrophages, was
observed in ApoE KO mice after HC consumption as compared
with WT fed on either ND or HC or ApoE KO mice fed ND,
independently of the time-period. In WT mice, HC consumption
for 10 weeks also augmented macrophage infiltration; however no
significant differences were observed after 5 weeks of HC intake
(Figure 2A–B). Hyperlipidemic ApoE KO mice fed a HC diet for
5 or 10 weeks presented an increased presence of inflammatory
chemokines RANTES and MCP-1, as compared with WT fed
either ND or HC (Figure 2A and 2C). HC also increased the
expression of both chemokines in WT mice, but only after 10
weeks of intervention. At this time, ApoE KO mice on ND
presented higher RANTES and MCP-1 expression than WT mice
on ND. Determination of RANTES and MCP-1 mRNA
expression by quantitative RT-PCR analysis confirmed these
results (Figure 2D). Furthermore, ApoE KO mice fed a HC diet
for 5 or 10 weeks presented higher superoxide anion levels, as
determined by DHE staining, indicating the presence of an
increased oxidative stress in these animals (Figure 2E).
Klotho mRNA and Protein are Decreased in
Hyperlipidemic Renal Injury
In normolipemic WT mice, Klotho expression was mainly
detected in both proximal and distal tubules from the renal cortex,
whereas no positive staining was observed in the renal medulla
(Figure 3A–B). A non-significant trend toward decrease in renal
Klotho content was observed in WT mice fed HC diet, as
determined by Western blot (Figure 3C). Interestingly, HC
caused a significant reduction in the renal expression of Klotho in
hyperlipidemic ApoE KO, and this effect was markedly observed
after 10 weeks of intervention. The same results were obtained
when we determined Klotho mRNA expression by quantitative
RT-PCR, suggesting that hyperlipidemia could downregulate
renal Klotho expression (Figure 3D).
Oxidized-LDL Decrease Klotho Expression and Increase
Proinflammatory Cytokines and Oxidative Stress in
Cultured Renal Tubular Cells
Hyperlipidemia is accompanied by formation of ox-LDL,
leading to increased oxidative stress and inflammatory cytokine
production, changes that could modulate Klotho expression [22–
26]. Therefore, to analyze the mechanisms involved in the
modulation of Klotho by hyperlipidemia in vivo, we incubated
cultured renal cells in presence of ox-LDL. Since Klotho is mainly
produced by proximal and distal tubules in the mouse kidney, our
in vitro studies were conducted in both mouse proximal (MCT) and
distal (NP-1) tubular epithelial cells. Cells were stimulated with
different concentrations of ox-LDL (0–50 mg/mL) based on
viability dose–response studies (Figure S2). Oil red staining
revealed that MCTs were able to uptake ox-LDL, as determined
by increased neutral lipid accumulation (Figure 4A). Importantly,
ox-LDL decreased Klotho mRNA expression in a time- and dose-
dependent manner (Figure 4B–C). Moreover, ox-LDL also
decreased Klotho protein, as reported by Western blot and
immunofluorescence in MCT (Figure 4D–E). Similar results
were observed in NP-1 cell cultures (Fig. S3).
Because inflammation and oxidative stress have been reported
to decrease renal Klotho expression, we analyzed whether ox-LDL
promotes the activation of these pathological pathways in tubular
epithelial cells. The addition of ox-LDL to MCT cell cultures
changed their quiescent epithelial phenotype into a pro-inflam-
matory one, characterized by increased IL-6, RANTES, MCP-1
and TNF-a gene expression (Figure 5A–B). ELISA analysis also
showed increased secretion of soluble RANTES, MCP-1 and IL-6
proteins in ox-LDL stimulated cells (Figure 5C–E). Nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase activation is a
major source of reactive oxygen species (ROS) in renal cells [34].
Therefore, we measured ROS generation after ox-LDL treatment
in tubular cells. As expected, ox-LDL increased ROS production
mediated by NADPH oxidase in MCT (Figure 5F). Furthermore,
exposure to ox-LDL augmented intracelular superoxide anion
levels in MCT, as determined by DHE staining (Figure 5G).
Figure 4. Oxidized LDL decrease Klotho expression in cultured tubular cells. (A) Oil-Red-O staining in murine proximal tubular cells (MCT)
showing increased lipid accumulation after 24 h incubation with ox-LDL (25 mg/mL). Ox-LDL decreases Klotho mRNA expression, as determined by
quantitative RT-PCR, in a time (B) and dose-dependent manner (C) in proximal tubular cells (MCT). Mean6SD of three independent experiments.
*p,0.05 vs control. Klotho protein expression, as determined by Western blot (D) and confocal microscopy (E), in MCT treated with ox-LDL (25 mg/
mL) for 24 h. Indirect immunofluorescence using anti-Klotho with secondary Alexa Fluor 488–conjugated antibody (green). Nuclei were stained with
propidium iodide (PI, red). Images are representative of three independent experiments.
doi:10.1371/journal.pone.0083713.g004
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Regulation of Klotho Expression by ox-LDL in Cultured
Tubular Cells
Oxidized-LDL modulate gene expression by different signaling
pathways [35–39]. To gain insight into the molecular mechanisms
of Klotho downregulation by ox-LDL in tubular cells, the effect of
inhibitors of distinct signaling pathways was further analyzed in
MCT cultures. As shown in Figure 6, inhibitors of PI3K/Akt
(LY294002), JNK (SP600125) and p38 (SB203580) did not affect
the ability of ox-LDL to decrease Klotho mRNA and protein
expression. In contrast, inhibitors of NF-kB (Parthenolide) and
ERK (PD98059) restored the mRNA and protein expression levels
of Klotho in ox-LDL incubated cells (Figure 6A–B). As shown in
Figure 6C, the NF-kB and ERK pathways were activated by ox-
LDL in MCT. Therefore, both NF-kB and ERK signaling
pathways are involved in ox-LDL-induced decrease of Klotho
expression in tubular cells.
Discussion
In the present study, we have demonstrated that renal Klotho
expression is decreased in hypercholesterolemic ApoE-KO mice
fed a high-fat diet. Furthermore, our results suggest that ox-LDL
could be related to the reduction of Klotho expression in tubular
epithelial cells. Finally, we have identified NF-kB and ERK as the
signaling pathways involved in the ox-LDL mediated Klotho
decrease.
Klotho is a membrane protein highly expressed in the kidney
that binds to FGF23, a hormone that induces phosphate excretion
into urine and regulates vitamin D synthesis. Klotho has been also
found in a soluble form, in human plasma and cell culture
supernatants. The secreted Klotho protein increases endothelium-
dependent nitric oxide synthesis and confers resistance to oxidative
stress [15]. As a result, lack of Klotho in mice results in accelerated
aging and development of age-related systemic disorders, such as
atherosclerosis [10,40]. Atherosclerosis is frequently found in
subjects with CKD, increasing the morbidity and mortality of
these patients [41,42]. However, the physiological mechanisms
involved in the association of renal failure and atherosclerosis
remains to be elucidated. Recently, Klotho has been proposed to
play an important role in this association. Thus, a decreased renal
Klotho expression was reported in an experimental model of
accelerated atherosclerosis in mice with CKD [43]; but the
intrinsic factors regulating Klotho in this pathological condition
are unknown. In this article we provide evidence for a role of
hyperlipidemia in attenuation of Klotho expression.
Hyperlipidemia, specifically hypercholesterolemia, plays an
important role in the induction of both vascular and renal injury
[2,3] and is an independent risk factor for CKD progression [44].
In this context, ApoE knockout mouse fed a high-fat diet, which
displays massive cholesterol accumulation, is a well-accepted
model for studying the effects of early onset hyperlipidemia on
renal damage [27,28]. Renal pathophysiological alterations in this
model included lipid accumulation, macrophage infiltration,
glomerular infiltration with foam cells and lipid deposits, and
expanded mesangium, consistent with previous reports [6,27].
Previous studies in hyperlipidemic rats with non-insulin-dependent
diabetes [45] or hypercholesterolemic uremic atherosclerotic
ApoE KO mice reported a decreased renal klotho gene expression
[43]. However, these studies did not specifically address whether
hyperlipidemia-associated renal damage modifies Klotho expres-
sion. In our study, we observed that renal Klotho mRNA and
protein expression decreased as hyperlipidemia increased. Thus,
hyperlipidemic ApoE KO mice fed a HC diet showed the lowest
Klotho mRNA and protein values whereas normolipidemic WT
on ND had the highest ones.
In our study, the changes in Klotho gene expression were
accompanied by aggravation of renal lesions in ApoE KO mice,
suggesting that Klotho could be involved in protection from
hyperlipidemic renal damage. In line with this, renal Klotho
expression was found to be downregulated in experimental models
of CKD and AKI [18–20,22] and in patients with CKD [21]. By
contrast, in vivo Klotho gene delivery ameliorates renal damage
and improves renal function in experimental models of kidney
injury [20,46].
Studies in hypercholesterolemic animal models showed that
renal injury was accompanied by increased oxidative stress and
inflammation [7,8], changes that may decrease Klotho expression,
as previously reported [22,25,26]. In our study ApoE KO mice fed
HC displayed an inflammatory state characterized by enhanced
macrophage infiltration, inflammatory chemokine expression
(MCP-1 and RANTES) and oxidative stress in renal lesions.
Increased kidney inflammation and oxidation, per se, could
explain, at least in part, the lower Klotho expression observed in
these hyperlipidemic animals. However the increased renal
cholesterol content in mice fed HC diet and the general
acceptance of the pathogenic role of LDL, particularly in its
oxidized form, in renal injury [5–9], point to ox-LDL as a
potential factor that may regulate Klotho expression in the
hyperlipidemic state and may be situated upstream of inflamma-
tion.
Oxidized-LDL may affect the behavior of several renal cells
types, including tubular epithelial cells [5,6]. In pathological
conditions, including CKD, renal tubular epithelial cells may be
exposed to ox-LDL [5]. Oxidized modified lipoproteins have been
identified in human kidney tissues [47] and are more abundant in
plasma and kidneys from hyperlipidemic animals [48,49].
Injurious actions of ox-LDL include induction of inflammation,
oxidation and apoptosis, all of them processes associated with
progression of renal disease [5,50,51]. Our in vitro study demon-
strates that ox-LDL increased IL-6, RANTES, MCP-1 and TNF-
a expression and secretion, and induced oxidative stress by
increasing NADPH-oxidase mediated ROS production and
intracellular superoxide anion levels. Interestingly, our data show
for the first time that ox-LDL decreased both Klotho mRNA and
protein expression in a time- and dose-dependent manner in
cultured tubular epithelial cells. In agreement with our observa-
tions, previous studies reported that statin treatment, by decreasing
cholesterol levels, significantly improved atherosclerotic lesions
and vascular damage in rats via enhancing Klotho expression
[24,52].
The mechanism responsible for ox-LDL-induced Klotho down-
regulation was also explored in the present study. It is known that
Figure 5. Oxidized-LDL stimulates expression and secretion of pro-inflammatory chemokines and ROS production by proximal
tubular MCT cells. (A) Quantitative RT-PCR analyses of IL-6, TNF-a, RANTES and MCP-1 in MCT stimulated with ox-LDL (25 mg/mL) at different time
points. (B) Quantitative RT-PCR analyses of IL-6, TNF-a, RANTES and MCP-1 in MCT stimulated with ox-LDL at different doses (0–25 mg/mL). Values for
chemokines were normalized to GAPDH expression and results are expressed as fold-change vs control. (C–E) Secretion of RANTES, MCP-1 and IL-6
(at 18 and 24 h) in MCT treated with 25 mg/mL ox-LDL. Supernatants were tested by ELISA. (F) NADPH-dependent ROS production in MCT cells
treated with ox-LDL (25 mg/ml) for 24 h. (G) Representative DHE staining of MCT cells under basal conditions and stimulated with ox-LDL (25 mg/ml)
for 24 h. Mean6SD of 3 independent experiments. *p,0.05 vs control.
doi:10.1371/journal.pone.0083713.g005
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ox-LDL mediate harmful effects through the activation of a variety
of signaling pathways, including MAPK [35], ERK [36], protein
kinase C [36], PI3K/Akt [36], and NF-kB [39]. However, the
intracellular pathways regulating renal Klotho expression are less
known. In a recent study, we demonstrated that the inflammatory
cytokines TWEAK and TNF-a downregulate Klotho in renal
tubular cells through an NF-kB-dependent mechanism [19].
Moreover, the RAS/MEK/ERK signaling cascade is involved
in endothelial growth factor-induced activation of the Klotho
promoter [53]. Here, we observed that ox-LDL promotes a rapid
and transient activation of both ERK and NFkB signaling
pathways in murine tubular cells. Moreover, blockade of the
MEK-dependent pathway of ERK activation with PD98059 or
blockade of NF-kB activation with parthenolide significantly
reduced the biological effects of ox-LDL on Klotho expression,
suggesting the involvement of both pathways in ox-LDL-induced
Klotho decrease in tubular epithelium.
In conclusion, the present study reveals that hyperlipidemia
induces inflammation, oxidative stress and accelerates renal
damage in ApoE KO mice; and this is accompanied by down-
regulation of Klotho expression. In addition, our data show that
ox-LDL decrease Klotho expression in tubular cells through
activation of ERK and NF-kB. These results suggest that Klotho
may be a key element explaining the relationship between
hyperlipidemia, aging and renal disease.
Supporting Information
Figure S1 Representative Oil-Red-O staining in C57BL/
6 (WT) and ApoE knockout (ApoE) mice fed normal or
hyperlipidemic diets (HC) for 10 weeks. Note the
glomerular lipid accumulation in ApoE KO mice, especially in
those fed HC (arrows).
(TIF)
Figure S2 Cell viability studies. Proximal (MCT, A) and
distal (NP-1, B) tubular epithelial cells were cultured for 24 hours
in the presence of ox-LDL (0–25 mg/mL). Flow cytometry
diagrams of permeabilized, propidium iodide–stained cells,
showed no significant increase in apoptosis. Inset: Examples of
nuclear morphology. Propidium iodide staining of permeabilized
cells (original magnification6800).
(TIF)
Figure S3 Oxidized LDL decrease Klotho expression in
cultured tubular distal cells. Ox-LDL decreases Klotho
mRNA expression, as determined by quantitative RT-PCR, in a
time (A) and dose-dependent manner (B) in distal tubular epithelial
cells (NP-1). Mean6SD of three independent experiments.
*p,0.05 vs control. Klotho protein expression, as determined by
Western blot (C) and confocal microscopy (D), in NP-1 treated
with ox-LDL (25 mg/mL) for 24 h. Indirect immunofluorescence
using anti-Klotho with secondary Alexa Fluor 488–conjugated
antibody (green). Nuclei were stained with propidium iodide (PI,
red). Images are representative of three independent experiments.
(TIF)
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